Respiratory disorders are common in the Australian community. One common disorder is asthma, which affects around 10% of the population. Another common disorder is chronic obstructive pulmonary disease (COPD), which affects between 10-20% of people over the age of 40 – around 2.1 million Australians at any one time. Lung cancer is the fourth most commonly diagnosed cancer and the most common cause of cancer-related death in both men and women.
Other conditions that IBAS is actively involved in researching include fibrotic lung diseases, such as pulmonary fibrosis, mesothelioma and bronchiectasis.
All respiratory disorders have a range of negative health outcomes for those affected. Given how essential breathing is to everything we do, the specific symptoms of the condition can be both debilitating and frightening. The ongoing effects of a respiratory illness can lead to frequent hospitalisations and affects people’s ability to work and enjoy their lives.
Respiratory diseases burden people experiencing the disease as well as their family, friends and carers. In addition, respiratory disease places a financial burden on the Australian community. These costs include health and hospital costs as well as lost productivity.
Since the Institute was established in 2000, our team has led successful research in a number of key areas including:
IBAS also runs clinical trials that are sponsored by pharmaceutical companies – these trials can provide individuals with access to new treatments as well as benefitting society by advancing our knowledge of treatments.
Respiratory research focuses on conditions including asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), lung cancer and the treatment of dyspnoea caused by a range of conditions.
To see current IBAS respiratory projects, click here.
As breathing and sleep disorders often overlap, our research into breathing and sleep disorders are interlinked. To find out more about our sleep research, click here.
More information on respiratory disorders can be found at the following websites:
|If you have concerns about yours or someone else’s breathing, please either:
HEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDY
Interested to participate in a study investigating the effect of fatigue on driving performance?
Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...
Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...
WORLD SLEEP DAY ON 17TH MARCH 2023
The benefits of quality sleep and to acknowledge the issue of sleep problems and their medical, educational, and social aspects as well as the prevention and management of sleep disorders, is promoted on World Sleep Day on the 17th March 2023.
A/PROF MARK HOWARD IS LISTED IN 'THE AUSTRALIAN'
The Australian's Research magazine names the top researcher and top research institution in each field of research, based on the number of citations for papers published in the top 20 journals in each field over the past five years.
PROF ANNE HOLLAND WINS THE 2022 ERS ALLIED HEALTH MEDAL
Congratulations Anne Holland for winning the ERS Mid-Career Gold Medal for Allied Health Professionals in recognition of her potential for further outstanding research within a field of the allied health professions. Well Done Anne!
IBAS SUCCESS IN 2022 AMRF RESEARCH GRANT SCHEME
Congratulations to the following IBAS staff members who have been successful in obtaining research funding from the Austin Medical Research Foundation (AMRF) for 2022.
Institute for Breathing and Sleep
Level 5, Harold Stokes Building, Austin Health
145 Studley Road
Heidelberg, Victoria, 3084
(03) 9496 5390